Delivery Order SPE2DB20D9329-SPE2DB22FD4LU
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued up to $1,629.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued up to $499,999,999, that runs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,580 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a $1,629.60 firm fixed-price delivery order, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to treat opioid overdose. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program,...
- This federal contract award, valued at $6,790.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4557037430 NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product used to treat opioid overdoses. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,405.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which...
- This federal contract award is a delivery order valued at $4,074.00 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,888.80 fixed-price contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,222 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical overdose reversal medication. The contract has no set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award, valued at $4,074.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- This federal contract award, valued at $6,790.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which provides...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB22FD4LUDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,518.40 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The award is part of DMS Pharmaceutical Group's significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables to the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 4/26/22 |